• FirefoxUpgrade to the new Firefox »
  •  Dow Up2.43% Nasdaq Up2.24%

    Keryx Biopharmaceuticals Inc. (KERX)

    -NCM
    14.67 Up 0.57(4.08%) Dec 18, 4:00PM EST
    Add to Portfolio
    Cash FlowGet Cash Flow for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
    Net Income (46,732) (22,721) (28,123)
    Operating Activities, Cash Flows Provided By or Used In
    Depreciation54  35  47  
    Adjustments To Net Income5,953  (472)1,846  
    Changes In Accounts Receivables -  7  (7)
    Changes In Liabilities7,291  (1,727)3,820  
    Changes In Inventories -   -   -  
    Changes In Other Operating Activities(885)115  (406)
    Total Cash Flow From Operating Activities (34,319) (24,763) (22,822)
    Investing Activities, Cash Flows Provided By or Used In
    Capital Expenditures(346)(24)(57)
    Investments -  4,212  (4,111)
    Other Cash flows from Investing Activities -   -   -  
    Total Cash Flows From Investing Activities (346) 4,188   (4,168)
    Financing Activities, Cash Flows Provided By or Used In
    Dividends Paid -   -   -  
    Sale Purchase of Stock75,684   -  33,830  
    Net Borrowings -   -   -  
    Other Cash Flows from Financing Activities -   -   -  
    Total Cash Flows From Financing Activities 75,684   -   33,830  
    Effect Of Exchange Rate Changes -   -   -  
    Change In Cash and Cash Equivalents 41,019   (20,575) 6,840  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.